Total trials
140
Active
36
Phase 3
4
Total enrollment
590,357
Pipeline matrix
Showing 2 of 2 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Essential Amino Acids Supplementation intervention | — | — | — | — | — | 1 | |
| Osteopathic Manipulative Therapy and Exercise Therapy | — | — | — | — | — | 1 |
Next readouts
- 2025-04-07
- 2029-12-26
Top conditions
- Anxiety5
- Stress5
- Obesity4
- Cancer4
- Breast Cancer4
- Autism Spectrum Disorder4
- Pregnancy3
- Depression3
Frequently asked questions about Michigan State University
- How many clinical trials does Michigan State University have on ClinicalTrials.gov?
- Michigan State University is listed as the lead sponsor on 140 clinical trials in ClinicalTrials.gov, 36 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Michigan State University's trials are in Phase 3?
- 4 of Michigan State University's trials are in Phase 3, spread across 2 active drug programs.
- What therapeutic areas does Michigan State University focus on?
- Michigan State University's most-studied conditions on ClinicalTrials.gov are Anxiety, Stress, Obesity, Cancer, Breast Cancer.
- When are Michigan State University's next clinical trial readouts?
- Michigan State University has 2 upcoming primary-completion readouts tracked here; the soonest is “Treating Chronic Cervicogenic Head and Neck Pain”, expected around 2025-04-07.